Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Massive rotator cuff tears are notoriously hard to treat, and superior capsular reconstruction (SCR) is one of several surgical options — but experts say its role is narrower than early enthusiasm suggested. SCR works best for young, active patients with no significant arthritis and preserved shoulder strength. More high-quality, long-term studies are needed to determine the optimal technique, graft choice, and patient selection.
Massive, irreparable posterosuperior rotator cuff tears affect a significant portion of patients with rotator cuff disease, and no single surgical approach has proven definitively superior. Superior capsular reconstruction (SCR) — an arthroscopic technique first described in 2012 — aims to restore normal shoulder biomechanics by reconstructing the superior capsule, recentering the humeral head, and relieving pain and weakness. Multiple graft options exist (tensor fascia lata autograft, dermal allograft, and long head of biceps tendon autograft), with systematic reviews showing broadly similar outcomes across graft types, though variability between individual studies remains high.
Experts emphasize that SCR has a narrow but real role: it's best suited for young, active patients with an intact subscapularis, mild or no glenohumeral arthritis, and at least 3/5 abduction and external rotation strength — but not true pseudoparalysis. Compared with reverse total shoulder arthroplasty (TSA), SCR yields similarly high functional outcomes, with patients more likely to return to their preoperative sports level, though long-term survivorship data remain limited.
Why it matters: With rotator cuff tears affecting up to 40% of the population and roughly 20–40% classified as massive, orthopedic surgeons face complex, high-stakes decisions. Clearer evidence on SCR's optimal use could help prevent overuse, reduce revision surgeries, and preserve joint function in younger patients who aren't yet candidates for shoulder replacement.